Johns Hopkins Center Receives Five-Year, $8 Mil. NCCAM Grant
This article was originally published in The Tan Sheet
Executive Summary
A new complementary medicine center at Johns Hopkins University initially will concentrate on alternative therapies for breast and prostate cancer.
You may also be interested in...
CAM Cancer Research Targeted In NCCAM-NCI Program Announcement
NCCAM and the National Cancer Institute issued a program announcement Dec. 17 seeking to stimulate research into complementary and alternative cancer therapies
Chinese herbs and breast cancer
Sixteen of 69 traditional Chinese botanical and zoological remedies "exhibited pronounced effects (>75% growth inhibition) on at least one" of five breast cancer cell lines, Michael Campbell, et al., University of California-San Francisco, report at AACR meeting. "Future studies with these crude aqueous extracts may lead to the isolation of novel active anti-tumor compounds," researchers note in poster abstract. Johns Hopkins University is studying use of Chinese herbals in breast and prostate cancer treatment (1"The Tan Sheet" Oct. 9, 2000, p. 15)
Vitamin/Herb CAM Therapies Common Among Cancer Outpatients - Survey
Almost 63% of cancer outpatients surveyed who were familiar with vitamin/herb complementary and alternative medicine reported using the therapies, according to a study in the July issue of the Journal of Clinical Oncology.